Page last updated: 2024-08-25

zoledronic acid and Sclerosis, Systemic

zoledronic acid has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balbir-Gurman, A; Bank, I; Braun-Moscovici, Y; Fisch, P; Migalovich Sheikhet, H; Villacorta Hidalgo, J	1

Other Studies

1 other study(ies) available for zoledronic acid and Sclerosis, Systemic

Article	Year
Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate. Frontiers in immunology, 2018, Volume: 9 Topics: Adult; Aged; Cardiolipins; Cells, Cultured; Cytokines; Diphosphonates; Female; Humans; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Male; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Scleroderma, Systemic; T-Lymphocyte Subsets; Zoledronic Acid	2018

Article

Year

Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.

Frontiers in immunology, 2018, Volume: 9

Topics: Adult; Aged; Cardiolipins; Cells, Cultured; Cytokines; Diphosphonates; Female; Humans; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Male; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Scleroderma, Systemic; T-Lymphocyte Subsets; Zoledronic Acid

2018